TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2017

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer.

James Chih-Hsin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.